FUMAGALLI, MARTA
 Distribuzione geografica
Continente #
EU - Europa 10.335
NA - Nord America 9.151
AS - Asia 8.962
SA - Sud America 781
AF - Africa 152
OC - Oceania 95
Continente sconosciuto - Info sul continente non disponibili 14
Totale 29.490
Nazione #
US - Stati Uniti d'America 8.851
CN - Cina 3.407
IT - Italia 2.511
SG - Singapore 2.352
GB - Regno Unito 2.231
DE - Germania 1.933
RU - Federazione Russa 846
HK - Hong Kong 806
SE - Svezia 731
BR - Brasile 588
VN - Vietnam 521
FR - Francia 446
IN - India 385
JP - Giappone 305
BD - Bangladesh 259
IE - Irlanda 251
FI - Finlandia 236
KR - Corea 235
NL - Olanda 220
TR - Turchia 202
CA - Canada 200
DK - Danimarca 159
ID - Indonesia 159
UA - Ucraina 152
BE - Belgio 107
ES - Italia 106
CH - Svizzera 84
AU - Australia 83
PL - Polonia 76
MX - Messico 63
AT - Austria 55
AR - Argentina 52
EU - Europa 52
GR - Grecia 48
TW - Taiwan 43
CO - Colombia 42
PH - Filippine 38
CI - Costa d'Avorio 37
CL - Cile 36
IQ - Iraq 35
PT - Portogallo 28
ZA - Sudafrica 26
IL - Israele 25
SA - Arabia Saudita 25
EC - Ecuador 24
PK - Pakistan 20
UY - Uruguay 20
EG - Egitto 19
UZ - Uzbekistan 19
MY - Malesia 18
NO - Norvegia 17
CZ - Repubblica Ceca 16
IR - Iran 15
AE - Emirati Arabi Uniti 13
KE - Kenya 13
TH - Thailandia 13
NZ - Nuova Zelanda 12
HU - Ungheria 11
MA - Marocco 11
RO - Romania 10
RS - Serbia 10
AZ - Azerbaigian 9
JO - Giordania 9
SC - Seychelles 9
TN - Tunisia 8
VE - Venezuela 8
NP - Nepal 7
PA - Panama 7
XK - ???statistics.table.value.countryCode.XK??? 7
EE - Estonia 6
GE - Georgia 6
LT - Lituania 6
NG - Nigeria 6
BA - Bosnia-Erzegovina 5
BY - Bielorussia 5
CR - Costa Rica 5
KZ - Kazakistan 5
PY - Paraguay 5
AL - Albania 4
BG - Bulgaria 4
BO - Bolivia 4
DZ - Algeria 4
JM - Giamaica 4
KW - Kuwait 4
LB - Libano 4
LU - Lussemburgo 4
QA - Qatar 4
SI - Slovenia 4
BB - Barbados 3
ET - Etiopia 3
HR - Croazia 3
KG - Kirghizistan 3
LK - Sri Lanka 3
MO - Macao, regione amministrativa speciale della Cina 3
MR - Mauritania 3
AM - Armenia 2
BF - Burkina Faso 2
BZ - Belize 2
DO - Repubblica Dominicana 2
MD - Moldavia 2
Totale 29.492
Città #
Southend 1.722
Singapore 1.422
Milan 1.111
Ashburn 828
Hong Kong 694
Beijing 619
Hanover 606
Dallas 591
San Jose 494
Frankfurt am Main 465
Chandler 463
Council Bluffs 291
Ann Arbor 275
Fairfield 269
Wilmington 267
Princeton 258
Dublin 243
Santa Clara 241
Seattle 238
Dearborn 215
Los Angeles 198
Shanghai 198
Sunnyvale 196
Houston 193
Nanjing 191
Woodbridge 171
New York 162
Guangzhou 151
Hefei 145
Ho Chi Minh City 143
Mountain View 141
Hanoi 135
Redwood City 135
Lauterbourg 129
Helsinki 125
Bengaluru 120
Cambridge 117
Grafing 117
Tokyo 117
Jakarta 104
Rome 101
Redmond 100
The Dalles 97
Buffalo 95
Des Moines 94
Boardman 91
Berlin 87
Shenyang 84
Moscow 83
Phoenix 81
Seoul 75
Columbus 68
Istanbul 65
Changsha 63
São Paulo 62
Boston 61
Jinan 60
Hangzhou 58
Jacksonville 58
Brussels 55
Cangzhou 54
London 54
Tianjin 54
Serra 51
Warsaw 49
Wuhan 48
Rio de Janeiro 46
Toronto 46
Ottawa 45
Hebei 44
Somerville 44
Chicago 43
Nuremberg 43
Athens 40
Medford 40
Zhengzhou 40
Andover 39
Fuzhou 38
Abidjan 37
Shenzhen 35
Leipzig 34
Sakarya 34
Paris 33
Bari 31
Bogotá 31
Chongqing 31
Naples 30
Munich 29
San Diego 29
Bühl 28
Nanchang 28
Stockholm 28
Chengdu 27
Jiaxing 27
Turin 27
Melbourne 26
Brooklyn 23
Da Nang 23
Santiago 23
Xian 23
Totale 17.293
Nome #
Pharmacological Properties and Biological Functions of the GPR17 Receptor, a Potential Target for Neuro-Regenerative Medicine 1.210
Regulation and signaling of the GPR17 receptor in oligodendroglial cells 777
Microglial vesicles improve post-stroke recovery by preventing immune cell senescence and favoring oligodendrogenesis 748
HEBE project: Healthy aging versus inflamm-aging: The role of physical exercise in modulating the biomarkers of age-associated and environmentally determined chronic diseases, study protocol 670
The concise guide to pharmacology 2021/22 : G protein-coupled receptors 569
Improvement of fiber connectivity and functional recovery after stroke by montelukast, an available and safe anti-asthmatic drug 545
CNS remyelination as a novel reparative approach to neurodegenerative diseases : The roles of purinergic signaling and the P2Y-like receptor GPR17 525
Detrimental and protective action of microglial extracellular vesicles on myelin lesions: astrocyte involvement in remyelination failure 506
The ubiquitin ligase Mdm2 controls oligodendrocyte maturation by intertwining mTOR with G protein-coupled receptor kinase 2 in the regulation of GPR17 receptor desensitization 483
Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels 476
The Concise Guide to PHARMACOLOGY 2023/24: G protein-coupled receptors 426
Differential local tissue permissiveness influences the final fate of GPR17-expressing oligodendrocyte precursors in two distinct models of demyelination 397
The recently identified P2Y-like receptor GPR17 is a sensor of brain damage and a new target for brain repair 392
Surface Plasmon Resonance as a Tool for Ligand Binding Investigation of Engineered GPR17 Receptor, a G Protein Coupled Receptor Involved in Myelination 346
The role of oligodendrocyte precursor cells expressing the GPR17 receptor in brain remodeling after stroke 340
How to reprogram microglia toward beneficial functions 334
Development of the first in vivo GPR17 ligand through an iterative drug discovery pipeline: A novel disease-modifying strategy for multiple sclerosis 328
The orphan receptor GPR17 identified as a new dual uracil nucleotides/cysteinyl-leukotrienes receptor 306
The Concise Guide to Pharmacology 2019/20: G protein-coupled receptors 290
Deciphering remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties : An in silico approach 282
Purinergic control of T cell activation by ATP released through pannexin-1 hemichannels 280
N-(phenyl)-2-[[3-(phenyl)-1H-1,2,4-triazol-5-yl]thio]-acetamide derivatives and related compounds as G protein coupled receptor 17 (GPCR17) modulators for use in the treatment of neuro-degenerative diseases 275
MicroRNAs change the games in central nervous system pharmacology 272
A role for P2X7 in microglial proliferation 264
Deciphering and modelling remyelinating mechanisms induced by clinically-used azole antifungals with exploitable repurposing properties 262
P2 receptors in human heart : upregulation of P2X6 in patients undergoing heart transplantation, interaction with TNFα and potential role in myocardial cell death 257
Cloning, pharmacological characterisation and distribution of the rat G-protein-coupled P2Y(13) receptor 254
Abnormal upregulation of gpr17 receptor contributes to oligodendrocyte dysfunction in SOD1G93A mice 252
CysLT(1) leukotriene receptor antagonists inhibit the effects of nucleotides acting at P2Y receptors 251
Montelukast improves disease outcome in SOD1G93A female mice by counteracting oligodendrocyte dysfunction and aberrant glial reactivity 237
Rewiring of Glucose and Lipid Metabolism Induced by G Protein-Coupled Receptor 17 Silencing Enables the Transition of Oligodendrocyte Progenitors to Myelinating Cells 236
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Overview 234
TNF Production and Release from Microglia via Extracellular Vesicles : Impact on Brain Functions 232
Pathophysiological roles of extracellular nucleotides in glial cells: Differential expression of purinergic receptors in resting and activated microglia 230
Regulation of oligodendrocyte functions : targeting lipid metabolism and extracellular matrix for myelin repair 230
Purinergic receptors on oligodendrocyte progenitors : promising targets for myelin repair in multiple sclerosis? 230
Functional characterization of two isoforms of the P2Y-like receptor GPR17: [35S]GTPgammaS binding and electrophysiological studies in 1321N1 cells 229
Dysregulation of GPR17, a key receptor involved in oligodendrocyte maturation, as a novel potential pathogenetic mechanism in demyelinating diseases 229
P2Y receptors in GtoPdb v.2023.1 227
Expression pattern and distribution of the oligodendroglial receptor GPR17 in Experimental Autoimmune Encephalomyelitis, a mouse model of Multiple Sclerosis 222
Role of P2Y receptors in trigeminal pain signalling 220
Oligodendrocyte Dysfunction in Amyotrophic Lateral Sclerosis: Mechanisms and Therapeutic Perspectives 217
Extracellular purine and pyrimidine nucleotides as local extrinsic regulators of adult neural progenitor cells in the diseased CNS 213
A role for the P2Y-like GPR17 receptor in oligodendrocyte differentiation 212
The Concise Guide to PHARMACOLOGY 2025/26: G protein-coupled receptors 211
The P2Y-like GPR17 receptor orchestrates the transition between immature and myelinating oligodendrocytes and is a new target for myelin repair 208
The expression and intracellular trafficking of the P2Y-like receptor GPR17 in oligodendroglial cells 206
The immune-inflammatory response of oligodendrocytes in a murine model of preterm white matter injury: the role of TLR3 activation 206
Role of P2Y purinergic receptors in neuron-glia signaling in trigeminal ganglia: involvement in pain transmission 205
P2Y receptors in GtoPdb v.2021.3 205
Stimulation of P2Y-like receptor GPR17 by both uracil nucleotides and cysteinyl-leukotrienes increases outward potassium currents in 1321N1 cells 204
G protein-coupled receptor 17 is regulated by WNT pathway during oligodendrocyte precursor cell differentiation 201
Extracellular vesicles released by microglia and macrophages carry endocannabinoids which foster oligodendrocyte differentiation 200
The purinergic system cooperates with the algogenic factors bradykinin and CGRP in modulating neuron/glia communication in mouse trigeminal ganglia from wild type and R192Q Cav2.1 knock-in mice: implications for basic mechanisms of migraine pain 200
Microglia is a key player in the reduction of stroke damage promoted by the new antithrombotic agent ticagrelor 198
Modulation of purinergic signaling by algogens in cultures from trigeminal sensory ganglia 196
Dysregulation of the GPR17 receptor in neuroinflammatory diseases: implications for remyelination in multiple sclerosis 195
GPR17-expressing oligodendrocyte precursor cells differentially react to damage in experimental autoimmune encephalomyelitis and cuprizone-induced demyelination 195
The P2Y-like receptor GPR17 as a sensor of damage and a target of CNS repair 194
High yield of adult oligodendrocyte lineage cells obtained from meningeal biopsy 194
Cys-leukotriene inhibitors also inhibit P2Y receptor-mediated signaling 193
The genetic inhibition of GPR17 affects myelination by influencing important players in oligodendrocyte maturation, including purinergic receptors 193
Purinergic neuron/glia communication in mouse trigeminal ganglia and its crosstalk with known algogenic mediators: implications for basic mechanisms of migraine pain 190
Characterisation of GPR17-expressing oligodendrocyte precursors in human ischaemic lesions and correlation with reactive glial responses 188
Cellular and Molecular Characterization of Multipolar Map5-Expressing Cells: A Subset of Newly Generated, Stage-Specific Parenchymal Cells in the Mammalian Central Nervous System 187
Cross-talk between microglia and oligodendroglial progenitors in cerebral ischemia: implications for new purinergic strategies to brain repair 186
Expression of GPR17 receptor in a murine model of perinatal brain neuroinflammation and its possible interaction with Wnt pathway 184
Comparative evaluation of GPR17 ligands in silico and in vitro on cultured primary oligodendrocyte precursor cells 182
Calcitonin gene-related peptide-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in mouse trigeminal ganglia from wild-type and R192Q Cav2.1 Knock-in mice: implications for basic mechanisms of migraine pain 181
Gene regulation of the receptor GPR17 in oligodendroglial cells: expression pattern and pathological alterations in a mouse model of multiple sclerosis 180
GPR17 Receptor Modulators 177
Altered Purinergic Signaling in Neurodevelopmental Disorders: Focus on P2 Receptors 173
Purinergic neuron/glia communication in the spinal-trigeminal system in vitro and in vivo: implications for basic mechanisms of pain transmission 173
Purinoceptor-mediated calcium signaling in primary neuron-glia trigeminal cultures 171
Crosstalk between the purinergic system and known algogenic mediators in mouse trigeminal ganglia : implications for basic mechanisms of migraine pain 170
GPR17 Receptor Modulators 169
New mechanisms regulating myelination in the central nervous system : the role of GPR17 and of a novel micro-RNA 169
The multiple faces of extracellular vesicles released by microglia: Where are we 10 years after? 168
Gpr17 receptor modulators 168
Crosstalk between sensory neurons and neuroinflammatory cells in trigeminal ganglia in relation to migraine pain 168
Pathophysiological Role of Purines and Pyrimidines in Neurodevelopment: Unveiling New Pharmacological Approaches to Congenital Brain Diseases 168
CGRP-mediated enhancement of purinergic neuron/glia communication by the algogenic factor bradykinin in trigeminal mouse ganglia : implications for migraine pain 167
Changes of the GPR17 receptor, a new target for neurorepair, in neurons and glial cells in patients with traumatic brain injury 166
Investigating the cross-talk between microglia and oligodendrocyte progenitors in brain ischemia 165
Dysregulation of GPR17, a key receptor involved in NG2 progenitor cells differentiation to mature oligodendrocytes, as a novel potential pathogenetic mechanism in demyelinating diseases 164
Gene regulation of the P2Y-like receptor GPR17 in oligodendrocytes, and pathological alterations in a mouse model of multiple sclerosis 164
ATP as a neurotransmitter of pain in migraine: a functional role for P2Y receptors in primary cultures from mouse trigeminal sensory ganglia 162
Modulatori del recettore gpr17 162
Does GRK-β arrestin machinery work as a "switch on" for GPR17-mediated activation of intracellular signaling pathways? 161
Pharmacological and biotechnological in vitro approaches unveil the role of GPR17 signaling in regulating the timing of oligodendroglial differentiation 158
International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy 157
Phenotypic changes, signaling pathway, and functional correlates of GPR17-expressing neural precursor cells during oligodendrocyte differentiation 155
Role of the P2Y-like receptor GPR17 in neural precursor cells 155
Functional roles of extracellular vesicles derived from microglia with diverse activation states 155
GPR17 Receptor Modulators 154
The GPR17 receptor in NG2 expressing cells : focus on in vivo cell maturation and participation in acute trauma and chronic damage 150
P2Y receptors in brain astroglial cells : Identification of a gliotic P2Y receptor coupled to activation of a calcium independent Ras/ERK1/2 pathway 149
Promoting re-myelination in MS via the GPR17 receptor, a new key actor in oligodendrogenesis 149
GPR17 Receptor Modulators 149
GPR17 Receptor Modulators 147
Totale 25.660
Categoria #
all - tutte 84.730
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 84.730


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021522 0 0 0 0 0 0 0 0 0 0 409 113
2021/20223.104 208 168 136 152 297 370 345 274 234 305 229 386
2022/20232.363 365 181 243 225 257 430 69 118 244 43 108 80
2023/20242.392 104 116 230 259 444 104 89 207 101 150 295 293
2024/20254.356 215 410 166 352 362 198 284 433 233 413 395 895
2025/20268.973 881 618 1.052 697 786 637 1.268 520 1.077 653 784 0
Totale 30.661